iCell Bioscience
iCell Bioscience Inc.(iCell) has been a recognized premier global biological materials resource and standards organization focusing on acquisition, authentication, production and preservation of high-quality human and animal primary cells, Cell lines and other cell biology products. iCell also provides CRO services and customized options to support your custom biological needs.
iCell possesses the largest and most complete primary cell bank and cell line bank in China. They have isolated and purified more than 800 types of primary cells and possess more than 400 types of cell lines from a wide range of species. The total number of cells used for scientific research from their cell bank is more than 15,000 vials. iCell’s cell biology products and custom services support life science and drug discovery and development. Over the years, iCell has become the leader in innovative research and development of primary cells and iPS cells in China. With the distinctive advantages of their original and creative technology in the biological and biomedical field, iCell has established good collaborative relationships with more than 1,000
The prices are on request! Contact Us by e-mail info@sobekbio.com
GA International
GA International has over 20 years of experience as a leading manufacturer of specialty labels, supplying laboratory identification solutions to biomedical research labs, hospitals, and other healthcare institutions. Since its inception, GA International has become a worldwide leader in cryogenic and chemical-resistant labels, with a strong dedication to R&D and customer service.
GA International is committed to providing reliable products and services that meet customer and regulatory requirements through their ISO 9001:2015 certified quality management system.
The prices are on request! Contact Us by e-mail info@sobekbio.com
DIMA Biotech
DIMA Biotechnology Ltd. is a biotech company focusing on preclinical R&D products and services for druggable targets. They plan to complete the preparation of lead antibody molecules for all druggable targets in the next 3-5 years. DIMA Biotech provides multiple pre-prepared lead antibody molecules for each target to help pharmaceutical companies skip the tedious steps of monoclonal antibody platform establishment and lead molecule screening. Therefore, companies can have more time to focus on the biological mechanism and developability study of drug targets, thus accelerating the process of new drug R&D.
Over the years, DIMA Biotech has been deeply engaged in developing and optimizing the underlying technology platforms for preclinical research. Currently, they have established two independently developed core technology platforms:
Single/multiple transmembrane protein eukaryotic expression, preparation and purification platforms, apply mammalian cell expression systems, provide ECD or full-length membrane protein products closest to native conformation and functional validation. In addition, DIMA Biotech has developed five major functional full-length transmembrane protein preparation systems, including Membrane Nanoparticle (MNP), Virus-Like Particle (VLP), Exosome (EXO), Detergent and Synthetic Nanodisc. Thousands of drug target protein products are in stock.
DimAb® High-throughput single B-cell lead antibody molecule discovery platform. DIMA Biotech has completed the preparation and screening of lead antibody molecules against more than 200 drug targets by this platform in just two years. Moreover, they have formed strategic partnerships with several international pharmaceutical enterprises and licensed several drug target molecules. DIMA’s preclinical development strength is widely recognized by the industry.
The prices are on request! Contact Us by e-mail info@sobekbio.com